Literature DB >> 18678470

Abnormal expression of glutamate transporter and transporter interacting molecules in prefrontal cortex in elderly patients with schizophrenia.

Deborah Bauer1, Daya Gupta, Vahram Harotunian, James H Meador-Woodruff, Robert E McCullumsmith.   

Abstract

Glutamate cycling is critically important for neurotransmission, and may be altered in schizophrenia. The excitatory amino acid transporters (EAATs) facilitate the reuptake of glutamate from the synaptic cleft and have a key role in glutamate cycling. We hypothesized that expression of the EAATs and the EAAT regulating proteins ARHGEF11, JWA, G-protein suppressor pathway 1 (GPS1), and KIAA0302 are altered in the brain in schizophrenia. To test this, we measured expression of EAAT1, EAAT2, EAAT3, and EAAT interacting proteins in postmortem tissue from the dorsolateral prefrontal and anterior cingulate cortex of patients with schizophrenia and a comparison group using in situ hybridization and Western blot analysis. We found increased EAAT1 transcripts and decreased protein expression, increased EAAT3 transcripts and protein, and elevated protein expression of both GPS1 and KIAA0302 protein. We did not find any changes in expression of EAAT2. These data indicate that proteins involved in glutamate reuptake and cycling are altered in the cortex in schizophrenia, and may provide potential targets for future treatment strategies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18678470      PMCID: PMC2656372          DOI: 10.1016/j.schres.2008.06.012

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  80 in total

1.  Expression of the human excitatory amino acid transporter 2 and metabotropic glutamate receptors 3 and 5 in the prefrontal cortex from normal individuals and patients with schizophrenia.

Authors:  T Ohnuma; S J Augood; H Arai; P J McKenna; P C Emson
Journal:  Brain Res Mol Brain Res       Date:  1998-05

2.  Proton magnetic resonance spectroscopy of the anterior cingulate region in schizophrenia.

Authors:  R F Deicken; L Zhou; N Schuff; M W Weiner
Journal:  Schizophr Res       Date:  1997-10-17       Impact factor: 4.939

3.  Reproducibility of proton magnetic resonance spectroscopic imaging in patients with schizophrenia.

Authors:  A Bertolino; J H Callicott; S Nawroz; V S Mattay; J H Duyn; G Tedeschi; J A Frank; D R Weinberger
Journal:  Neuropsychopharmacology       Date:  1998-01       Impact factor: 7.853

4.  1H magnetic resonance spectroscopy characterization of neuronal dysfunction in drug-naive, chronic schizophrenia.

Authors:  B Y Choe; K T Kim; T S Suh; C Lee; I H Paik; Y W Bahk; K S Shinn; R E Lenkinski
Journal:  Acad Radiol       Date:  1994-11       Impact factor: 3.173

Review 5.  Glutamate in schizophrenia: clinical and research implications.

Authors:  D C Goff; L Wine
Journal:  Schizophr Res       Date:  1997-10-30       Impact factor: 4.939

6.  Multiple signaling pathways regulate cell surface expression and activity of the excitatory amino acid carrier 1 subtype of Glu transporter in C6 glioma.

Authors:  K E Davis; D J Straff; E A Weinstein; P G Bannerman; D M Correale; J D Rothstein; M B Robinson
Journal:  J Neurosci       Date:  1998-04-01       Impact factor: 6.167

7.  A widely expressed betaIII spectrin associated with Golgi and cytoplasmic vesicles.

Authors:  M C Stankewich; W T Tse; L L Peters; Y Ch'ng; K M John; P R Stabach; P Devarajan; J S Morrow; S E Lux
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

8.  Proton magnetic resonance spectroscopy in the frontal and temporal lobes of neuroleptic naive patients with schizophrenia.

Authors:  K M Cecil; R E Lenkinski; R E Gur; R C Gur
Journal:  Neuropsychopharmacology       Date:  1999-02       Impact factor: 7.853

9.  Molecular cloning and expression of the rat EAAT4 glutamate transporter subtype.

Authors:  C L Lin; A V Tzingounis; L Jin; A Furuta; M P Kavanaugh; J D Rothstein
Journal:  Brain Res Mol Brain Res       Date:  1998-12-10

Review 10.  In vivo neurochemistry of the brain in schizophrenia as revealed by magnetic resonance spectroscopy.

Authors:  L S Kegeles; T J Humaran; J J Mann
Journal:  Biol Psychiatry       Date:  1998-09-15       Impact factor: 13.382

View more
  56 in total

1.  Astrocyte and glutamate markers in the superficial, deep, and white matter layers of the anterior cingulate gyrus in schizophrenia.

Authors:  Pavel Katsel; William Byne; Panos Roussos; Weilun Tan; Larry Siever; Vahram Haroutunian
Journal:  Neuropsychopharmacology       Date:  2011-01-26       Impact factor: 7.853

2.  Acute elevations of brain kynurenic acid impair cognitive flexibility: normalization by the alpha7 positive modulator galantamine.

Authors:  Kathleen S Alexander; Hui-Qiu Wu; Robert Schwarcz; John P Bruno
Journal:  Psychopharmacology (Berl)       Date:  2011-10-26       Impact factor: 4.530

Review 3.  Translational potential of astrocytes in brain disorders.

Authors:  Alexei Verkhratsky; Luca Steardo; Vladimir Parpura; Vedrana Montana
Journal:  Prog Neurobiol       Date:  2015-09-16       Impact factor: 11.685

4.  Increased G protein-coupled receptor kinase (GRK) expression in the anterior cingulate cortex in schizophrenia.

Authors:  Adam J Funk; Vahram Haroutunian; James H Meador-Woodruff; Robert E McCullumsmith
Journal:  Schizophr Res       Date:  2014-08-19       Impact factor: 4.939

5.  Mutant mouse models: genotype-phenotype relationships to negative symptoms in schizophrenia.

Authors:  Colm M P O'Tuathaigh; Brian P Kirby; Paula M Moran; John L Waddington
Journal:  Schizophr Bull       Date:  2009-11-24       Impact factor: 9.306

6.  Abnormal partitioning of hexokinase 1 suggests disruption of a glutamate transport protein complex in schizophrenia.

Authors:  Dan Shan; Daniel Mount; Stephen Moore; Vahram Haroutunian; James H Meador-Woodruff; Robert E McCullumsmith
Journal:  Schizophr Res       Date:  2014-02-21       Impact factor: 4.939

Review 7.  cAMP guided his way: a life for G protein-mediated signal transduction and molecular pharmacology-tribute to Karl H. Jakobs.

Authors:  Klaus Aktories; Peter Gierschik; Dagmar Meyer Zu Heringdorf; Martina Schmidt; Günter Schultz; Thomas Wieland
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-05-17       Impact factor: 3.000

8.  Regional differences in expression of β-tubulin isoforms in schizophrenia.

Authors:  Mark S Moehle; Richard F Luduena; Vahram Haroutunian; James H Meador-Woodruff; Robert E McCullumsmith
Journal:  Schizophr Res       Date:  2012-01-20       Impact factor: 4.939

Review 9.  Stress-induced deficits in cognition and emotionality: a role of glutamate.

Authors:  Carolyn Graybeal; Caryl Kiselycznyk; Andrew Holmes
Journal:  Curr Top Behav Neurosci       Date:  2012

10.  Regional decoupling of N-acetyl-aspartate and glutamate in schizophrenia.

Authors:  Nina V Kraguljac; Meredith A Reid; David M White; Jan den Hollander; Adrienne C Lahti
Journal:  Neuropsychopharmacology       Date:  2012-07-18       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.